on 14 Dec 2021
Last Applicant/ Owned by
Suji-gu, Yongin-si Gyeonggi-do
KR
Serial Number
79300505 filed on 13th Nov 2020
Registration Number
6585436 registered on 14th Dec 2021
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Ophthalmic preparations; pharmaceutical products for the treatment of viral and infectious disease, for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceuticals for the treatment of cancer disease, neurodegenerative disease, neurodevelopmental disorder, eye disease, muscular disease, infectious disease, cardiovascular disease, gastrointestinal disease, blood di Read More
Ophthalmic preparations; pharmaceutical products for the treatment of viral and infectious disease, for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceuticals for the treatment of cancer disease, neurodegenerative disease, neurodevelopmental disorder, eye disease, muscular disease, infectious disease, cardiovascular disease, gastrointestinal disease, blood disease, metabolic disease, immune disease, genetic disease; pharmaceutical preparations acting on the central nervous system for the treatment of dementia, Alzheimer's disease, Parkinson's disease, Huntington's disease, neuromuscular disorders, neurodevelopmental disorders, neurovascular disease; anti-cancer preparations; cardiovascular pharmaceuticals; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for the use in hematology; anti-diabetic pharmaceuticals; pharmaceutical products for the treatment of infectious disease; anti-dermoinfectives; pharmaceutical preparations for the treatment of kidney disease; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations in the nature of autonomic drugs for medical purposes; pharmaceutical products for treating respiratory disease; pharmaceutical preparations for treating epidermal problems; viral vaccines; anti-viral agents, namely, anti-viral disinfectants; pharmaceutical and veterinary preparations for the treatment of cancer disease, neurodegenerative disease, eye disease, muscular disease, infectious disease, cardiovascular disease, gastrointestinal disease, blood disease, metabolic disease, immune disease, genetic disease
Research and development of vaccines and medicines; drug discovery services; scientific research for medical purposes in the field of cancerous disease; scientific research for medical purposes in the area of cancerous disease; research and development in the fields of pharmaceutical and biotechnology; testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; pharmaceutical products development; research on the subject of pharmaceuticals; clinical studies of medicines, namely, clinical research in the field of cancer therapy, neurodegenerative disease therapy, neurodevelopmental disorder therapy, eye disease therapy, muscular disease therapy, infectious disease therapy, cardiovascular disease therapy, gastrointestinal disease therapy, blood disease therapy, metabolic disease therapy, immune disease therapy, genetic disease therapy, radiology, chemotherapy; medical research services for assessing the efficiency of pharmaceuticals; pharmaceutical drug development services; scientific research in the field of pharmacy; consultancy pertaining to pharmacology; medicine research, namely, research and development of vaccines and medicines; testing of pharmaceuticals; research in the field of medical products; providing information on the test, inspection, and research of medical products; consultation and providing information in the fields of pharmacology; industrial research in the fields of medicine, health and pharmacology; analysis of human tissues for medical research
No 79300505
No Service Mark
No 16632L200250
No
No
No
No
No
No
No
No
26.01.21 -
Circles that are totally or partially shaded
26.01.29 -
Helixes
26.17.09 -
Curved line(s), band(s) or bar(s)
27.03.01 -
Geometric figures forming letters or numerals, including punctuation
Status Date | Action Taken |
---|---|
27th May 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
27th May 2022 | FINAL DISPOSITION PROCESSED |
14th Mar 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
14th Dec 2021 | REGISTERED-PRINCIPAL REGISTER |
12th Nov 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
28th Sep 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
28th Sep 2021 | PUBLISHED FOR OPPOSITION |
08th Sep 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
24th Aug 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
24th Aug 2021 | EXAMINER'S AMENDMENT ENTERED |